Foreign-Trade Zone (FTZ) 185-Culpeper, Virginia; Notification of Proposed Production Activity; Merck & Co., Inc. (Pharmaceutical Products); Elkton, Virginia, 13524 [2021-04863]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
13524
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Notices
Part 637, Chapter 4. Direction was
added to the Storage or Treatment of
Separated Solids section to design
storage facilities for separated solids in
accordance with the appropriate NRCS
standard. A consideration on the
biosecurity of separation facilities was
added.
Waste Transfer (Code 634):
Formatting and writing style were
updated to meet current agency
requirements. Minor revisions were
made for clarity and readability
purposes. The structural design
requirements were updated to align
with changes made to the National
Engineering Manual. The criteria for
reception pit size, pipe clean-outs and
pipeline velocity were revised.
Wastewater Treatment—Milk House
(Code 627): Added a new conservation
practice standard developed to better
address the technical complexities of
treating greywater from cleaning the
milking equipment. The practice
standard is based on several university
extension publications referenced in the
standard and NRCS field experience.
Wetland Creation (Code 658): The
standard revision removed soils as a
purpose and added an additional
purpose of creating a native plant
community adapted to growth and
regeneration in anerobic conditions.
Establishment of hydric soil was
removed as a purpose because anaerobic
soil conditions is an outcome, not a
purpose. The new practice standard
Wildlife Habitat Planting (Code 420) is
listed as appropriate for vegetative
establishment when wildlife habitat is a
purpose. This allows the use of Wetland
Creation (Code 658) when the purpose
is to establish a unique plant
community without targeting a single
species of wildlife or guild.
Windbreak/Shelterbelt Establishment
and Renovation (Code 380): Two
practice standards were combined, and
Code 380 now includes windbreak
renovation as well as establishment. The
definition, purpose, conditions where
practice applies, and considerations
sections were updated. Criteria sections
were added to address renovation;
several other sections were moved to the
Considerations section. The Plans and
Specifications section were expanded to
align with conservation plan
requirements, and operations and
maintenance sections were expanded to
clarify requirements. References were
added.
Terry Cosby,
Acting Chief, Natural Resources Conservation
Service.
[FR Doc. 2021–05005 Filed 3–8–21; 8:45 am]
BILLING CODE 3410–16–P
VerDate Sep<11>2014
17:03 Mar 08, 2021
Jkt 253001
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–16–2021]
Foreign-Trade Zone (FTZ) 185—
Culpeper, Virginia; Notification of
Proposed Production Activity; Merck &
Co., Inc. (Pharmaceutical Products);
Elkton, Virginia
Merck & Co., Inc. (Merck), submitted
a notification of proposed production
activity to the FTZ Board for its facility
in Elkton Virginia. The notification
conforming to the requirements of the
regulations of the FTZ Board (15 CFR
400.22) was received on March 2, 2021.
Merck already has authority to
produce pharmaceutical products
within Subzone 185C. The current
request would a add finished product
and foreign status materials to the scope
of authority. Pursuant to 15 CFR
400.14(b), additional FTZ authority
would be limited to the specific foreignstatus materials and specific finished
product described in the submitted
notification (as described below) and
subsequently authorized by the FTZ
Board.
Production under FTZ procedures
could exempt Merck from customs duty
payments on the foreign-status materials
used in export production. On its
domestic sales, for the foreign-status
materials/components noted below and
in the existing scope of authority, Merck
would be able to choose the duty rates
during customs entry procedures that
applies to PRIMAXIN/TIENAM
(imipenem/cilastatin) (duty-free). Merck
would be able to avoid duty on foreignstatus components which become scrap/
waste. Customs duties also could
possibly be deferred or reduced on
foreign-status production equipment.
The materials sourced from abroad are
BIS (2, 4-Dichlorophenyl)
Chlorophosphate and Enol Phosphate
(duty rate 6.5%). The request indicates
that the materials are subject to duties
under Section 301 of the Trade Act of
1974 (Section 301), depending on the
country of origin. The applicable
Section 301 decisions require subject
merchandise to be admitted to FTZs in
privileged foreign status (19 CFR
146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is April
19, 2021.
A copy of the notification will be
available for public inspection in the
‘‘Reading Room’’ section of the Board’s
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
website, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov.
Dated: March 4, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021–04863 Filed 3–8–21; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–17–2021]
Foreign-Trade Zone (FTZ) 93—Raleigh/
Durham, North Carolina; Notification of
Proposed Production Activity; LiebelFlarsheim Company, LLC (Diagnostic
Imaging Contrast Media), Raleigh,
North Carolina
Liebel-Flarsheim Company, LLC
(Liebel-Flarsheim) submitted a
notification of proposed production
activity to the FTZ Board for its facility
in Raleigh, North Carolina. The
notification conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.22) was
received on March 2, 2021.
The Liebel-Flarsheim facility is
located within FTZ 93. The facility is
used for the production of diagnostic
imaging contrast media. Pursuant to 15
CFR 400.14(b), FTZ activity would be
limited to the specific foreign-status
material/component and specific
finished product described in the
submitted notification (as described
below) and subsequently authorized by
the FTZ Board.
Production under FTZ procedures
could exempt Liebel-Flarsheim from
customs duty payments on the foreignstatus component used in export
production. On its domestic sales, for
the foreign-status material/component
noted below, Liebel-Flarsheim would be
able to choose the duty rate during
customs entry procedures that applies to
Dotarem® (gadoterate meglumine) (dutyfree). Liebel-Flarsheim would be able to
avoid duty on the foreign-status
material/component which becomes
scrap/waste. Customs duties also could
possibly be deferred or reduced on
foreign-status production equipment.
The material/component sourced
from abroad is dodecane tetraacetic acid
(DOTA) (duty rate—6.5%). The request
indicates that the material/component is
subject to duties under Section 301 of
the Trade Act of 1974 (Section 301),
depending on the country of origin. The
applicable Section 301 decisions require
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 86, Number 44 (Tuesday, March 9, 2021)]
[Notices]
[Page 13524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04863]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-16-2021]
Foreign-Trade Zone (FTZ) 185--Culpeper, Virginia; Notification of
Proposed Production Activity; Merck & Co., Inc. (Pharmaceutical
Products); Elkton, Virginia
Merck & Co., Inc. (Merck), submitted a notification of proposed
production activity to the FTZ Board for its facility in Elkton
Virginia. The notification conforming to the requirements of the
regulations of the FTZ Board (15 CFR 400.22) was received on March 2,
2021.
Merck already has authority to produce pharmaceutical products
within Subzone 185C. The current request would a add finished product
and foreign status materials to the scope of authority. Pursuant to 15
CFR 400.14(b), additional FTZ authority would be limited to the
specific foreign-status materials and specific finished product
described in the submitted notification (as described below) and
subsequently authorized by the FTZ Board.
Production under FTZ procedures could exempt Merck from customs
duty payments on the foreign-status materials used in export
production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, Merck
would be able to choose the duty rates during customs entry procedures
that applies to PRIMAXIN/TIENAM (imipenem/cilastatin) (duty-free).
Merck would be able to avoid duty on foreign-status components which
become scrap/waste. Customs duties also could possibly be deferred or
reduced on foreign-status production equipment.
The materials sourced from abroad are BIS (2, 4-Dichlorophenyl)
Chlorophosphate and Enol Phosphate (duty rate 6.5%). The request
indicates that the materials are subject to duties under Section 301 of
the Trade Act of 1974 (Section 301), depending on the country of
origin. The applicable Section 301 decisions require subject
merchandise to be admitted to FTZs in privileged foreign status (19 CFR
146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is April 19, 2021.
A copy of the notification will be available for public inspection
in the ``Reading Room'' section of the Board's website, which is
accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at
[email protected].
Dated: March 4, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-04863 Filed 3-8-21; 8:45 am]
BILLING CODE 3510-DS-P
